Cargando…

Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma

BACKGROUND: Increasing evidence indicated a close relationship between aberrant splicing variants and carcinoma, whereas comprehensive analysis of prognostic alternative splicing (AS) profiling in breast cancer (BRCA) is lacking and largely unknown. METHODS: RNA-seq data and corresponding clinical i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Dong, Duan, Yi, Cun, Jinjing, Yang, Qifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448481/ https://www.ncbi.nlm.nih.gov/pubmed/30984247 http://dx.doi.org/10.3389/fgene.2019.00278

Ejemplares similares

Profiles of prognostic alternative splicing signature in hepatocellular carcinoma
por: Wu, Fangming, et al.
Publicado: (2020)

Genome-Wide Profiling of Alternative Splicing Signature Reveals Prognostic Predictor for Esophageal Carcinoma
por: Sun, Jian-Rong, et al.
Publicado: (2020)

Comprehensive Analysis of Prognostic Alternative Splicing Signatures in Endometrial Cancer
por: Chen, Peigen, et al.
Publicado: (2020)

Alternative Splicing Events and Splicing Factors Are Prognostic in Adrenocortical Carcinoma
por: Lv, Jian, et al.
Publicado: (2020)

Survival-Associated Alternative Splicing Events and Prognostic Signatures in Pancreatic Cancer
por: Xu, Lichao, et al.
Publicado: (2020)

Construction of the prognostic signature of alternative splicing revealed the prognostic predictor and immune microenvironment in head and neck squamous cell carcinoma
por: Ye, Fan, et al.
Publicado: (2022)

Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma
por: Zhang, Dong, et al.
Publicado: (2019)

Identification of prognostic and metastasis-related alternative splicing signatures in hepatocellular carcinoma
por: Huang, Runzhi, et al.
Publicado: (2020)

Comprehensive Identification and Alternative Splicing of Microexons in Drosophila
por: Pang, Ting-Lin, et al.
Publicado: (2021)

Prognostic Alternative Splicing Signatures in Esophageal Carcinoma
por: Dlamini, Zodwa, et al.
Publicado: (2021)

A Novel Prognostic Index Based on Alternative Splicing in Papillary Renal Cell Carcinoma
por: Wu, Zhipeng, et al.
Publicado: (2020)

Prognostic Value and Potential Role of Alternative mRNA Splicing Events in Cervical Cancer
por: Shao, Xiang-yang, et al.
Publicado: (2020)

Identification of prognostic alternative splicing signature in gastric cancer
por: Wang, Zhiwu, et al.
Publicado: (2022)

Genome-Wide Transcriptional Analysis Reveals Alternative Splicing Event Profiles in Hepatocellular Carcinoma and Their Prognostic Significance
por: Xiong, Yongfu, et al.
Publicado: (2020)

Genome-wide identification of alternative splicing and splicing regulated in immune infiltration in osteosarcoma patients
por: Dai, Zhibing, et al.
Publicado: (2023)

Genome-Wide Identification of Immune-Related Alternative Splicing and Splicing Regulators Involved in Abdominal Aortic Aneurysm
por: Wu, Shiyong, et al.
Publicado: (2022)

Identification of Prognostic and Metastatic Alternative Splicing Signatures in Kidney Renal Clear Cell Carcinoma
por: Meng, Tong, et al.
Publicado: (2019)

Identification and Validation of an Immunological Expression-Based Prognostic Signature in Breast Cancer
por: Pei, Jianying, et al.
Publicado: (2020)

Identification of an Immune-Related Prognostic Signature Associated With Immune Infiltration in Melanoma
por: Liu, Nian, et al.
Publicado: (2020)

Identification of a chromatin regulator signature and potential prognostic ability for adrenocortical carcinoma
por: Li, Junwu, et al.
Publicado: (2022)

Prognostic Signatures of Alternative Splicing Events in Esophageal Carcinoma Based on TCGA Splice-Seq Data
por: Ye, Ping, et al.
Publicado: (2021)

Identification and Validation of an Immune-Related eRNA Prognostic Signature for Hepatocellular Carcinoma
por: Cai, Shenglan, et al.
Publicado: (2021)

Characterization of alternative splicing events and prognostic signatures in breast cancer
por: Han, Pihua, et al.
Publicado: (2021)

Identification of prognostic and bone metastatic alternative splicing signatures in bladder cancer
por: Huang, Runzhi, et al.
Publicado: (2021)

Identification of Bone Metastatic and Prognostic Alternative Splicing Signatures in Prostate Adenocarcinoma
por: Zhu, Jiwen, et al.
Publicado: (2023)

DASES: a database of alternative splicing for esophageal squamous cell carcinoma
por: Chen, Yilong, et al.
Publicado: (2023)

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Identification of a Six-Immune-Related Long Non-coding RNA Signature for Predicting Survival and Immune Infiltrating Status in Breast Cancer
por: Li, Zheng, et al.
Publicado: (2020)

Identification of prognostic and bone metastasis‐related alternative splicing signatures in mesothelioma
por: Huang, Runzhi, et al.
Publicado: (2021)

Identification of a Novel Glycosyltransferase Prognostic Signature in Hepatocellular Carcinoma Based on LASSO Algorithm
por: Zhou, Zhiyang, et al.
Publicado: (2022)

Comprehensive Analysis of Splicing Factor and Alternative Splicing Event to Construct Subtype-Specific Prognosis-Predicting Models for Breast Cancer
por: Zhang, He, et al.
Publicado: (2021)

Identification and validation of an alternative splicing-based prognostic signature for head and neck squamous cell carcinoma
por: Zhao, Xinyuan, et al.
Publicado: (2020)

Comprehensive Network Analysis Reveals Alternative Splicing-Related lncRNAs in Hepatocellular Carcinoma
por: Wang, Junqing, et al.
Publicado: (2020)

N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma
por: Maimaiti, Aierpati, et al.
Publicado: (2022)

Identification and Validation of Hypoxia-Related lncRNA Signature as a Prognostic Model for Hepatocellular Carcinoma
por: Zhou, Chenghui, et al.
Publicado: (2021)

Identification of a Six-lncRNA Signature With Prognostic Value for Breast Cancer Patients
por: Zhao, Erjie, et al.
Publicado: (2020)

Comprehensive analysis of prognostic alternative splicing signature in cervical cancer
por: Ouyang, Dong, et al.
Publicado: (2020)

Correction to: Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

The Functional Impact of Alternative Splicing on the Survival Prognosis of Triple-Negative Breast Cancer
por: Wu, Sijia, et al.
Publicado: (2021)

Genome-wide identification of alternative splicing associated with histone deacetylase inhibitor in cutaneous T-cell lymphomas
por: Yu, Shirong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0juomolpppnfkrf3b01bp47haj